nPTB, in turn, increases FGFR2 IIIc (mesenchymal-specific isoform) and pyruvate kinase M2 (PKM2) transcripts, which result in the progression and metabolic signature of CRC cells [133]. This evidence concerns the gene PTBP2 and colorectal carcinoma.